G1 Therapeutics, Inc. (NASDAQ:GTHX) Q3 2023 Earnings Call Transcript

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q3 2023 Earnings Call Transcript November 1, 2023

G1 Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, expectations were $-0.31.

Operator: Good day and thank you for standing by. Welcome to the G1 Therapeutics Third Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be...